Ken Griffin acquired 2.06 Million Beam Therapeutics shares worth $35.6 Million. That's 0.04% of their equity portfolio (615th largest holding). The investor owns 1.75% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q1 2020. Since then Ken Griffin bought shares twelve more times and sold shares on six occasions. The investor's estimated purchase price is $71.7 Million, resulting in a loss of 50%.